1
Home
Companies

Lipella Pharmaceuticals

Lipella Pharmaceuticals
Leadership team

Dr. Jonathan Kaufman M.B.A., Ph.D. (Co-Founder, Chairman, CEO, Pres, Sec. & Treasurer)

Dr. Michael B. Chancellor M.D. (Co-Founder, Chief Medical Officer, Consultant & Director)

Mr. Douglas Johnston CPA (Chief Financial Officer)

Products/ Services
Biotechnology, Developer Platform, Therapeutics
Number of Employees
0 - 50
Headquarters
Pittsburgh, Pennsylvania, United States
Established
2005
Company Registration
SEC CIK number: 0001347242
Traded as
NASDAQ:LIPO
Social Media
URL
https://www.lipella.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. The company was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.
History

Founded in 2014, Lipella Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to developing novel therapeutics to treat rare and often neglected diseases. Lipella's lead product is an oral small molecule currently undergoing Phase III clinical trials.

Mission
Our mission is to develop novel therapies to improve the lives of patients suffering from rare and often neglected diseases.
Vision
Our vision is to create meaningful progress in both medicine and rare disease research, resulting in innovative therapeutics that positively impact patients in need.
Key Team

Allison Houck (Director of Fin.)

Ms. Michele Gruber (Director of Operations)

Recognition and Awards
Lipella has been awarded the Top 10 Biotech Companies Award by the American Biotech Association in 2019 and 2020.
References

https://in.investing.com/equities/lipella-pharmaceuticals

https://finance.yahoo.com/quote/LIPO/profile?p=LIPO

https://www.crunchbase.com/organization/lipella-pharmaceuticals

https://www.lipella.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Lipella Pharmaceuticals
Leadership team

Dr. Jonathan Kaufman M.B.A., Ph.D. (Co-Founder, Chairman, CEO, Pres, Sec. & Treasurer)

Dr. Michael B. Chancellor M.D. (Co-Founder, Chief Medical Officer, Consultant & Director)

Mr. Douglas Johnston CPA (Chief Financial Officer)

Products/ Services
Biotechnology, Developer Platform, Therapeutics
Number of Employees
0 - 50
Headquarters
Pittsburgh, Pennsylvania, United States
Established
2005
Company Registration
SEC CIK number: 0001347242
Traded as
NASDAQ:LIPO
Social Media
URL
https://www.lipella.com